Ian Read

Chief executive: Pfizer Inc. (before 2014 to 1 Jan 2019)

11commitments announced

7with a clear outcome

5met on time

–rate shown after 15 outcomes

Commitments are credited to the chief executive in office on the day they were announced. Where a deadline fell after the leader left, the entry is marked. Sources for each leadership change: Pfizer Inc. filing.

Commitments announced under Ian Read

Pfizer Inc.announced 19 Dec 2018	Close the transaction to create a joint venture with GlaxoSmithKline due after leader left	Met31 Dec 2019
Pfizer Inc.announced 31 Oct 2017	Make Lyrica CR available in the U.S	No record found31 Jan 2018
Pfizer Inc.announced 2 May 2017	Report longer-term safety and efficacy results from the ongoing 54-week Inflectra clinical study	No record found31 Dec 2017
Pfizer Inc.announced 1 Nov 2016	Begin shipping Inflectra to wholesalers in the U.S	No record found30 Nov 2016
Pfizer Inc.announced 22 Aug 2016	Complete the acquisition of Medivation	Met31 Dec 2016
Pfizer Inc.announced 16 May 2016	Complete the acquisition of Anacor Pharmaceuticals	Met30 Sep 2016
Pfizer Inc.announced 8 Feb 2016	Create a new operating segment named Global Specialty and Consumer Brands	Not met31 Dec 2016
Pfizer Inc.announced 8 Feb 2016	Close the acquisition of Allergan plc	Withdrawn31 Dec 2016
Pfizer Inc.announced 8 Feb 2016	Combine the Vaccines and Oncology businesses with the Global Innovative Pharma business	Met31 Dec 2016
Pfizer Inc.announced 8 Feb 2016	Decide on the potential separation of the innovative and established businesses	Met31 Dec 2018
Pfizer Inc.announced 2 Feb 2016	Complete the combination with Allergan	No record found31 Dec 2016

Is this record wrong, or are you Ian Read? Add a statement or ask for a correction.

Commitments announced under Ian Read

The Deadline Report